Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Research Domains
  1. Home
  3. Research Domains

Related Concept Videos

  • Biomedical And Clinical Sciences
  • Oncology And Carcinogenesis
  • Predictive And Prognostic Markers
  • Potential Role For Peroxisome Proliferator Activated Receptor (ppar) In Preventing Colon Cancer.
  • Biomedical And Clinical Sciences
  • Oncology And Carcinogenesis
  • Predictive And Prognostic Markers
  • Potential Role For Peroxisome Proliferator Activated Receptor (ppar) In Preventing Colon Cancer.

    • Related Experiment Videos

    Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer.

    L Jackson1, W Wahli, L Michalik

    • 1Wolfon Digestive Diseases Centre, University of Nottingham, UK.

    Gut
    |August 13, 2003

    View abstract on PubMed

    Summary
    This summary is machine-generated.

    Peroxisome proliferator activated receptor (PPAR) expression is reduced in colorectal cancer. Activating PPAR with methylclofenapate inhibited polyp growth and cell proliferation, suggesting PPAR as a therapeutic target.

    Related Experiment Videos

    Area of Science:

    • Molecular biology
    • Oncology
    • Cellular biology

    Background:

    • Peroxisome proliferator activated receptors (PPARs) are nuclear receptors regulating cellular processes.
    • PPAR and PPAR are implicated in colorectal cancer development.
    • This study investigates the inhibitory role of PPAR in colorectal cancer.

    Purpose of the Study:

    • To determine PPAR expression levels in colorectal cancer.
    • To evaluate the effect of PPAR activation on colorectal tumor progression.
    • To explore PPAR as a potential therapeutic target for colorectal cancer.

    Main Methods:

    • Compared PPAR mRNA and protein levels in cancer vs. non-malignant tissue.
    • Administered a PPAR activator (methylclofenapate) to APC(Min)/+ mice and quantified polyps.
    • Assessed methylclofenapate's effect on human colonic epithelial cell proliferation and apoptosis.

    Main Results:

    • PPAR expression was significantly lower in colorectal tumors compared to normal tissue.
    • Methylclofenapate treatment reduced polyp size in both small intestine and colon.
    • Methylclofenapate decreased cell proliferation but did not affect apoptosis.

    Conclusions:

    • PPAR activation may inhibit colorectal tumor progression.
    • Inhibition of proliferation is a potential mechanism for PPAR's anti-cancer effect.
    • PPAR represents a promising therapeutic target for colorectal cancer.